Clinical breakpoints

Clinical breakpoints

See information on Clinical breakpoint tables.

 

Breakpoint table for bacteria

 

Clinical breakpoints - bacteria (v 6.0) - pdf file for printing (2016-01-01 and 2016-01-20)

Clinical breakpoints - bacteria (v 6.0) - excel file for screen (2016-01-01 and 2016-01-20)

New files with the following corrections uploaded 2016-01-20:
- Cefuroxime oral breakpoint for Haemophilus influenzae corrected.
- Hidden row made visible for Staphylococcus spp. and “Cefoxitin (screen), Coagulase-negative staphylococci other than S. lugdunensis and S. saprophyticus".
- Hidden rows made visible for Enterococcus spp. and gentamicin and streptomycin.

Following consultation December 2015, the following changes were introduced in the final version of 6.0.

Addendum November 2016:

1. Ceftazidime-avibactam - clinical breakpoints and zone diameter correlates published 8 November, 2016.

2. Fosfomycin - EUCAST recommendations for MIC- and disk diffusion testing published 8 November, 2016.

 

Consultation on 2017 v 7.0 Breakpoint table.

Every year, EUCAST publishes next year´s breakpoint tables 2-3 weeks in advance to consult with all users. The final version will be published on the 1st of January 2017 both as an Excel version for use on screen and as a pdf-file for printing. The preliminary table is only published in Excel.

The preliminary version of the EUCAST Clinical Breakpoint Tables v. 7.0 is now open for consultation (1-15 December). We encourage users to report errors, including typos. Please address these to Erika Matuschek no later than the 15 December, 2016.

The most important news and changes in version 7.0 are
- Breakpoints added for ceftazidime-avibactam, nitroxoline and fosfomycin (zone diameter).
- All fluoroquinolone breakpoints have been reviewed and several revised (MIC and zone diameter).

- Disk diffusion method and breakpoints (MIC and zone diameter) for Aerococcus sanguinicola and urinae and for Kingella kingae. Please note that the consultation for these breakpoints is still open and that small changes might appear in the final version of the table (1 January 2017).
- A few zone diameter breakpoints for various organisms/groups have been revised.
- ECOFFs and breakpoints for agents that are used topically have been moved from the Guidance document into the Breakpoint table, and updated accordingly.

- Dosages have been added for several agents.  

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Breakpoints published in Addendum during the year will be part of the next version of the full Clinical breakpoint tables valid from early January each year.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Breakpoint table for Candida spp and Aspergillus spp

 

Clinical breakpoints - fungi (v 8.0) - pdf file for printing (2015-11-16)

Clinical breakpoints - fungi (v 8.0) - excel file for screen (2015-11-16)


- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Breakpoints published in Addendum during the year will be part of the next version of the full Clinical breakpoint tables valid from early January each year.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Previous versions of breakpoint tables

 

Previous versions of breakpoint tables. 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Definitions of clinical breakpoints and epidemiological cut off values

 

 

 

 

Last update: 07 April 2013